• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7213
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/27/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that shaft break occurred.The >60% stenosed target lesion was located in the severely calcified and tortuous diagonal artery.A 3.00mm x 15mm nc emerge balloon catheter was advanced for dilatation.However, when the balloon was introduced into the lesion, the 6-inch proximal part of the shaft broke partially outside of the body.The detached portion of the device was simply pulled out of the patient.The procedure was completed successfully.No patient complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: nc emerge mr 3.00mm x 15mm, catheter was returned for analysis.Visual, tactile and microscopic analysis was performed on the device.A visual and tactile examination identified multiple kinks along the length of the hypotube shaft and a shaft break 38.5 cm distal to the distal end of the strain relief.A visual and tactile inspection of the outer and inner lumen and of the entire extrusion found no issues.A detailed microscopic examination of the balloon material identified no tear or pinhole in the balloon.The proximal and distal markerbands identified no damage.Tip showed no signs of tip damage.
 
Event or Problem Description
It was reported that shaft break occurred.The >60% stenosed target lesion was located in the severely calcified and tortuous diagonal artery.A 3.00mm x 15mm nc emerge balloon catheter was advanced for dilatation.However, when the balloon was introduced into the lesion, the 6-inch proximal part of the shaft broke partially outside of the body.The detached portion of the device was simply pulled out of the patient.The procedure was completed successfully.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC EMERGE
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key19716484
Report Number2124215-2024-41266
Device Sequence Number8206939
Product Code LOX
UDI-Device Identifier08714729846529
UDI-Public08714729846529
Combination Product (Y/N)N
PMA/510(K) Number
K141236
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/05/2026
Device Model Number7213
Device Catalogue Number7213
Device Lot Number0033559157
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/27/2024
Supplement Date Received by Manufacturer08/30/2024
Initial Report FDA Received Date07/10/2024
Supplement Report FDA Received Date09/02/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/05/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexMale
-
-